JP2000087093A - Detergent composition - Google Patents
Detergent compositionInfo
- Publication number
- JP2000087093A JP2000087093A JP10254739A JP25473998A JP2000087093A JP 2000087093 A JP2000087093 A JP 2000087093A JP 10254739 A JP10254739 A JP 10254739A JP 25473998 A JP25473998 A JP 25473998A JP 2000087093 A JP2000087093 A JP 2000087093A
- Authority
- JP
- Japan
- Prior art keywords
- viscosity
- long
- fatty acid
- term
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003599 detergent Substances 0.000 title claims abstract description 15
- 239000000203 mixture Substances 0.000 title claims description 25
- 239000003945 anionic surfactant Substances 0.000 claims abstract description 11
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims abstract description 5
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims abstract description 5
- 150000001342 alkaline earth metals Chemical class 0.000 claims abstract description 4
- 150000001412 amines Chemical class 0.000 claims abstract description 4
- 238000004140 cleaning Methods 0.000 claims description 11
- 125000002252 acyl group Chemical group 0.000 claims description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- 229910052783 alkali metal Inorganic materials 0.000 claims description 3
- 150000001340 alkali metals Chemical class 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 3
- 150000004670 unsaturated fatty acids Chemical group 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims 1
- 230000007774 longterm Effects 0.000 abstract description 32
- 238000004519 manufacturing process Methods 0.000 abstract description 12
- 239000003240 coconut oil Substances 0.000 abstract description 8
- 150000003839 salts Chemical class 0.000 abstract description 8
- 238000003860 storage Methods 0.000 abstract description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract description 7
- 229910052708 sodium Inorganic materials 0.000 abstract description 7
- 239000011734 sodium Substances 0.000 abstract description 7
- WPPOGHDFAVQKLN-UHFFFAOYSA-N N-Octyl-2-pyrrolidone Chemical compound CCCCCCCCN1CCCC1=O WPPOGHDFAVQKLN-UHFFFAOYSA-N 0.000 abstract description 6
- 239000003513 alkali Substances 0.000 abstract 1
- 238000011156 evaluation Methods 0.000 description 13
- 239000002453 shampoo Substances 0.000 description 12
- -1 alkyl taurine salt Chemical class 0.000 description 11
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 238000007796 conventional method Methods 0.000 description 9
- 229910052749 magnesium Inorganic materials 0.000 description 7
- 239000011777 magnesium Substances 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- NJPQAIBZIHNJDO-UHFFFAOYSA-N 1-dodecylpyrrolidin-2-one Chemical compound CCCCCCCCCCCCN1CCCC1=O NJPQAIBZIHNJDO-UHFFFAOYSA-N 0.000 description 6
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 6
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 6
- 239000002304 perfume Substances 0.000 description 6
- 238000004925 denaturation Methods 0.000 description 5
- 230000036425 denaturation Effects 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 3
- 235000019864 coconut oil Nutrition 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 3
- 235000010234 sodium benzoate Nutrition 0.000 description 3
- 239000004299 sodium benzoate Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- JPPRXACMNPYJNK-UHFFFAOYSA-N 1-docosoxydocosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCCCCCC JPPRXACMNPYJNK-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- SUZRRICLUFMAQD-UHFFFAOYSA-N N-Methyltaurine Chemical compound CNCCS(O)(=O)=O SUZRRICLUFMAQD-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 229920003086 cellulose ether Polymers 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 229960003080 taurine Drugs 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- KAKVFSYQVNHFBS-UHFFFAOYSA-N (5-hydroxycyclopenten-1-yl)-phenylmethanone Chemical compound OC1CCC=C1C(=O)C1=CC=CC=C1 KAKVFSYQVNHFBS-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000003826 Artemisia Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- LXJLWYCADUHFPJ-UHFFFAOYSA-N C(CCCCCCCCCCC)(=O)N(CCS(=O)(=O)O)C.[Mg] Chemical compound C(CCCCCCCCCCC)(=O)N(CCS(=O)(=O)O)C.[Mg] LXJLWYCADUHFPJ-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- 206010015946 Eye irritation Diseases 0.000 description 1
- 101100321669 Fagopyrum esculentum FA02 gene Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-N alpha-L-IdopA-(1->3)-beta-D-GalpNAc4S Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS(O)(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C(O)=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009052 artemisia Nutrition 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 231100000013 eye irritation Toxicity 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 1
- RVRFYZGKUZFYAH-UHFFFAOYSA-N n',n'-dimethylpropane-1,3-diamine;octadecanoic acid Chemical compound CN(C)CCCN.CCCCCCCCCCCCCCCCCC(O)=O RVRFYZGKUZFYAH-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- PYJBVGYZXWPIKK-UHFFFAOYSA-M potassium;tetradecanoate Chemical compound [K+].CCCCCCCCCCCCCC([O-])=O PYJBVGYZXWPIKK-UHFFFAOYSA-M 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- CAVXVRQDZKMZDB-UHFFFAOYSA-N sodium;2-[dodecanoyl(methyl)amino]ethanesulfonic acid Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CCS(O)(=O)=O CAVXVRQDZKMZDB-UHFFFAOYSA-N 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 229960005066 trisodium edetate Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Landscapes
- Detergent Compositions (AREA)
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は洗浄剤組成物に関す
る。さらに詳しくは、皮膚に対する安全性が高く、使用
上適度な粘性を有するとともに、その粘性が長期間安定
に維持され、かつpHの長期安定性に優れる、ヒトの皮
膚、毛髪等を洗浄するための洗浄剤組成物に関する。TECHNICAL FIELD The present invention relates to a cleaning composition. More specifically, for cleaning human skin, hair, etc., which has high safety to the skin and has an appropriate viscosity for use, the viscosity is maintained stably for a long time, and the pH is excellent in the long-term stability. The present invention relates to a cleaning composition.
【0002】[0002]
【従来の技術】従来、長鎖アシル低級アルキルタウリン
塩型陰イオン性界面活性剤は皮膚への安全性の高い洗浄
用成分として知られているが、身体、頭髪用洗浄剤に用
いた場合、使用上の適度な粘性を得るのが難しかった。
これを解決するために、脂肪酸アルキロールアミド(非
イオン性界面活性剤)や、きわめて高分子のカチオン性
セルロースエーテル等を併用することで粘性を得てい
た。2. Description of the Related Art Conventionally, long-chain acyl-lower alkyl taurine salt type anionic surfactants are known as cleansing ingredients having high safety to the skin. It was difficult to obtain a suitable viscosity for use.
In order to solve this, viscosity was obtained by using fatty acid alkylolamide (a nonionic surfactant) or a very high molecular weight cationic cellulose ether in combination.
【0003】しかしながら、脂肪酸アルキロールアミド
はタンパク質変性能が高いため、洗浄剤中に多量に配合
することは安全性の点から好ましくない。さらに、製造
されてから長い時間が経つにつれて商品のpHが上昇し
てアルカリ側に変化するなど、長期保存安定性の点にお
いても好ましくない。また、使用感の点においても、多
量配合した場合、髪や皮膚にごわつきを与え、さっぱり
感に欠けるという問題があった。また高分子のカチオン
性セルロースエーテルは長時間の経時で粘度が低下する
という不具合があった。[0003] However, fatty acid alkylolamide has a high protein-degrading ability, so that it is not preferable to mix it in a large amount in a detergent from the viewpoint of safety. Furthermore, it is not preferable in terms of long-term storage stability, for example, the pH of the product increases as the time elapses after production and changes to the alkaline side. In addition, from the viewpoint of feeling of use, when a large amount is blended, there is a problem that hair and skin are rough and lack freshness. In addition, the high molecular weight cationic cellulose ether has a disadvantage that the viscosity decreases with the elapse of a long time.
【0004】このような現況にあって、長鎖アシル低級
アルキルタウリン塩型陰イオン性界面活性剤を主洗浄成
分として用いた場合、使用上満足できる適度な粘性を継
続して維持することができ、しかも長期間経過してもp
Hの変化がみられない洗浄剤組成物の開発が望まれてい
た。Under such circumstances, when a long-chain acyl lower alkyl taurine salt type anionic surfactant is used as a main cleaning component, it is possible to continuously maintain a moderate viscosity which is satisfactory in use. And p
There has been a demand for the development of a detergent composition that does not show a change in H.
【0005】[0005]
【発明が解決しようとする課題】本発明は上記事情に鑑
みてなされたもので、皮膚に対する安全性が高く、使用
上適度な粘性を有するとともに、その粘性が長期間安定
に維持され、かつpHの長期安定性に優れる、ヒトの皮
膚、毛髪等を洗浄するための洗浄剤組成物を提供するこ
とを目的とする。DISCLOSURE OF THE INVENTION The present invention has been made in view of the above circumstances, and has a high degree of safety to the skin, has an appropriate viscosity for use, maintains the viscosity stably for a long period of time, and has a high pH. An object of the present invention is to provide a detergent composition for cleaning human skin, hair, and the like, which is excellent in long-term stability.
【0006】[0006]
【課題を解決するための手段】本発明者らは、上記事情
に鑑み鋭意研究を行った結果、長鎖アシル低級アルキル
タウリン塩型陰イオン性界面活性剤とN−アルキルピロ
リドンとを組み合わせることにより上記目的を達成し得
ることを見出し、これに基づき本発明を完成した。Means for Solving the Problems The present inventors have conducted intensive studies in view of the above circumstances, and as a result, have found that a long-chain acyl lower alkyl taurine salt type anionic surfactant is combined with an N-alkylpyrrolidone. The inventors have found that the above object can be achieved, and based on this, completed the present invention.
【0007】すなわち本発明は、(A)下記一般式
(I)That is, the present invention relates to (A) the following general formula (I)
【0008】[0008]
【化3】 (式中、R1COは平均炭素原子数8〜20の飽和また
は不飽和の脂肪酸残基(アシル基)を表し;R2は水素
原子または平均炭素原子数1〜3のアルキル基を表し;
M1はアルカリ金属類、アルカリ土類金属類、アンモニ
ウムまたは有機アミン類を表す)で表される長鎖アシル
低級アルキルタウリン塩型陰イオン性界面活性剤の1種
または2種以上と、(B)N−アルキルピロリドンの1
種または2種以上とを含有してなる洗浄剤組成物に関す
る。Embedded image (Wherein R 1 CO represents a saturated or unsaturated fatty acid residue (acyl group) having an average of 8 to 20 carbon atoms; R 2 represents a hydrogen atom or an alkyl group having an average of 1 to 3 carbon atoms;
M 1 represents an alkali metal, an alkaline earth metal, ammonium or an organic amine) and one or more of long-chain acyl-lower-alkyl-taurine-type anionic surfactants represented by (B) 1) N-alkylpyrrolidone
The present invention relates to a detergent composition comprising a seed or two or more kinds.
【0009】[0009]
【発明実施の形態】以下、本発明について詳述する。DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will be described below in detail.
【0010】本発明で用いられる(A)成分としての長
鎖アシル低級アルキルタウリン塩型陰イオン性界面活性
剤は、下記一般式(I)The long chain acyl lower alkyl taurine salt type anionic surfactant used as the component (A) in the present invention is represented by the following general formula (I):
【0011】[0011]
【化4】 (式中、R1COは平均炭素原子数8〜20の飽和また
は不飽和の脂肪酸残基(アシル基)を表し;R2は水素
原子または平均炭素原子数1〜3のアルキル基を表し;
M1はアルカリ金属類、アルカリ土類金属類、アンモニ
ウムまたは有機アミン類を表す)で表される。Embedded image (Wherein R 1 CO represents a saturated or unsaturated fatty acid residue (acyl group) having an average of 8 to 20 carbon atoms; R 2 represents a hydrogen atom or an alkyl group having an average of 1 to 3 carbon atoms;
M 1 represents an alkali metal, an alkaline earth metal, ammonium or an organic amine).
【0012】上記式中、R1COとしては、例えばC11
H23CO、C13H27CO、C15H31CO、C17H35C
O、C13H25CO、C15H29CO、ココヤシ油脂肪酸残
基、パームヤシ油脂肪酸残基等が挙げられる。なお、R
1COは、泡立ち、安全性等の点から、その平均炭素原
子数が10〜16のものがより好ましい。R2として
は、H、CH3、C2H5またはC3H7が挙げられる。ま
たM1としては、リチウム、カリウム、ナトリウム、カ
ルシウム、マグネシウム、アンモニウム、モノエタノー
ルアミン、ジエタノールアミン、トリエタノールアミン
等が例示される。In the above formula, R 1 CO is, for example, C 11
H 23 CO, C 13 H 27 CO, C 15 H 31 CO, C 17 H 35 C
O, C 13 H 25 CO, C 15 H 29 CO, coconut oil fatty acid residue, palm coconut oil fatty acid residue and the like. Note that R
1 CO is foaming, from the viewpoint of safety, the average number of carbon atoms is more preferably from 10 to 16. R 2 includes H, CH 3 , C 2 H 5 or C 3 H 7 . Examples of M 1 include lithium, potassium, sodium, calcium, magnesium, ammonium, monoethanolamine, diethanolamine, and triethanolamine.
【0013】(A)成分の好適具体例としては、N−コ
コイルタウリンナトリウム、N−ココイル−N−メチル
タウリンナトリウム、N−ラウロイル−N−メチルタウ
リンナトリウム、N−ヤシ油脂肪酸−N−メチルタウリ
ンナトリウム、N−ヤシ油脂肪酸−N−メチルタウリン
トリエタノールアミン、N−パーム油脂肪酸−N−エチ
ルタウリントリエタノールアミン、N−ココイルタウリ
ンマグネシウム、N−ココイル−N−メチルタウリンマ
グネシウム、N−ラウロイル−N−タウリンマグネシウ
ム、N−ラウロイル−N−メチルタウリンマグネシウ
ム、N−ヤシ油脂肪酸−Nメチルタウリンマグネシウム
等が例示されるが、これらに限定されるものではない。
中でも、N−ヤシ油脂肪酸−N−メチルタウリンナトリ
ウム、N−ヤシ油脂肪酸−N−メチルタウリントリエタ
ノールアミン、N−ヤシ油脂肪酸−Nメチルタウリンマ
グネシウム等が特に好ましい。本発明において(A)成
分は1種または2種以上を配合することができる。Preferred examples of component (A) include sodium N-cocoyltaurine, sodium N-cocoyl-N-methyltaurine, sodium N-lauroyl-N-methyltaurine, N-coconut fatty acid-N-methyltaurine. Sodium, N-coco fatty acid-N-methyl taurine triethanolamine, N-palm oil fatty acid-N-ethyl taurine triethanolamine, N-cocoyl taurine magnesium, N-cocoyl-N-methyl taurine magnesium, N-lauroyl- Examples thereof include, but are not limited to, magnesium N-taurine, magnesium N-lauroyl-N-methyltaurine, and N-coconut fatty acid-magnesium N-methyltaurine.
Among them, N-coconut fatty acid-N-methyltaurine sodium, N-coconut fatty acid-N-methyltaurine triethanolamine, N-coconut fatty acid-N-methyltaurine magnesium and the like are particularly preferable. In the present invention, the component (A) may be used alone or in combination of two or more.
【0014】本発明洗浄剤組成物中、(A)成分の配合
量は、配合される任意添加成分等によっても異なるが、
安全性、洗浄力等の点から5〜50重量%が好ましく、
特には10〜30重量%である。The amount of the component (A) in the detergent composition of the present invention varies depending on the optional components to be compounded.
From the viewpoint of safety, detergency, etc., 5 to 50% by weight is preferable,
In particular, it is 10 to 30% by weight.
【0015】本発明で用いられる(B)成分としてのN
−アルキルピロリドンとしては、下記一般式(II)N as the component (B) used in the present invention
-Alkyl pyrrolidone is represented by the following general formula (II)
【0016】[0016]
【化5】 (式中、R3は平均炭素原子数が8〜16の直鎖型のア
ルキル基を表す)で表される化合物が好ましい。R3と
しては、C8H17、C9H19、C10H21、C1 1H23、C12
H25、C13H27、C14H29、C15H31、C16H33等が具
体的に例示される。中でも、配合した場合の臭いの影響
などを考慮するとC8H17(=N−オクチルピロリド
ン)、C12H25(=N−ドデシルピロリドン)等が好ま
しい。(B)成分は、「SURFADONE LP-100」、「SURFAD
ONE LP-300」(以上、いずれも米国、International Sp
ecialty Products社製)等として市販されており、商業
的に入手可能である。本発明において(B)成分は1種
または2種以上を配合することができる。Embedded image (Wherein, R 3 represents a linear alkyl group having an average carbon number of 8 to 16). The R 3, C 8 H 17, C 9 H 19, C 10 H 21, C 1 1 H 23, C 12
H 25 , C 13 H 27 , C 14 H 29 , C 15 H 31 , C 16 H 33 and the like are specifically exemplified. Among them, C 8 H 17 (= N-octylpyrrolidone), C 12 H 25 (= N-dodecylpyrrolidone) and the like are preferable in consideration of the influence of the odor when blended. (B) The components are “SURFADONE LP-100”, “SURFAD
ONE LP-300 ”(both in the United States and International Sp
ecialty Products) and are commercially available. In the present invention, the component (B) may be used alone or in combination of two or more.
【0017】本発明洗浄剤組成物中、(B)成分の配合
量は、粘性の十分な発現という点から3〜7重量%が好
ましく、特には4〜6重量%である。The amount of the component (B) in the detergent composition of the present invention is preferably 3 to 7% by weight, particularly 4 to 6% by weight, from the viewpoint of sufficiently exhibiting viscosity.
【0018】ところで、(A)成分としての長鎖アシル
低級アルキルタウリン塩型陰イオン性界面活性剤は、起
泡性、洗浄性などの基本的な界面活性剤作用を有し、一
般的な陰イオン性界面活性剤に比較するとタンパク質変
性能も弱く、安全性が高いが、化粧品としての使い勝手
のよい適度な粘度を長期間維持し、かつ、製造当初のp
Hを長期間維持する系を得ることはきわめて難しい。The long chain acyl lower alkyl taurine salt type anionic surfactant as the component (A) has a basic surfactant action such as foaming property and detergency, and is a general anionic surfactant. Compared to ionic surfactants, protein degradation performance is weak and safety is high, but it maintains a moderate viscosity that is easy to use as cosmetics for a long time,
It is extremely difficult to obtain a system that maintains H for a long time.
【0019】本発明では、(A)成分である上記一般式
(I)で表される長鎖アシル低級アルキルタウリン塩型
陰イオン性界面活性剤と、(B)成分であるN−アルキ
ルピロリドンとを組み合わせて用いることにより、皮膚
への低刺激性を維持しつつ、同時に適度な粘度を長期間
維持し、かつ、製造当初のpHを長期間維持し得る洗浄
剤組成物を得ることに成功した。In the present invention, a long-chain acyl lower alkyltaurine salt type anionic surfactant represented by the above general formula (I) as the component (A) and an N-alkylpyrrolidone as the component (B) are used. By using a combination of these, it was possible to maintain a low irritation to the skin, and at the same time, maintain an appropriate viscosity for a long period of time, and succeeded in obtaining a detergent composition capable of maintaining the initial pH for a long period of time. .
【0020】本発明洗浄剤組成物の粘度は、30℃にて
B型粘度計(12rpm/1min)により測定した値
が300〜5000mPa・s、特には500〜300
0mPa・s程度のものが好ましい。本発明洗浄剤組成
物では、この粘度を長期間維持することができる。具体
的には、例えば本発明洗浄剤組成物の製造後1時間後の
粘度と、該組成物を45℃温度下で28日間保存した後
の粘度について、下記数1で示す粘度の変化率で粘度の
長期安定を評価した場合、粘度の変化率0.8〜1の長
期粘度安定性に優れた洗浄剤組成物を得ることができ
る。The viscosity of the cleaning composition of the present invention measured at 30 ° C. with a B-type viscometer (12 rpm / 1 min) is 300 to 5000 mPa · s, particularly 500 to 300 mPa · s.
It is preferably about 0 mPa · s. In the cleaning composition of the present invention, this viscosity can be maintained for a long time. Specifically, for example, the viscosity after one hour after the production of the cleaning composition of the present invention and the viscosity after storing the composition at a temperature of 45 ° C. for 28 days are represented by the rate of change of the viscosity shown by the following formula 1. When the long-term stability of the viscosity is evaluated, a detergent composition having a long-term viscosity stability of 0.8 to 1 in rate of change in viscosity can be obtained.
【0021】[0021]
【数1】粘度の変化率=(45℃、28日間保存後の粘度)
/(製造1時間後の粘度)## EQU1 ## Rate of change in viscosity = (viscosity after storage at 45 ° C. for 28 days)
/ (Viscosity 1 hour after production)
【0022】また、本発明洗浄剤組成物の製造当初のp
Hは5〜7程度が好ましく、特には5.5〜6.5程度
である。本発明洗浄剤組成物では、このpHを長期間維
持することができる。具体的には、例えば試料製造1時
間後のpH(25℃)と、試料製造後、45℃恒温槽に
て2ヶ月間保存した後の試料のpH(25℃)とから、
下記の数2で示す式からpHの変化量を算出した場合、
その変化量が0.2未満の洗浄剤組成物が得られる。Further, the p value at the beginning of the production of the detergent composition of the present invention is
H is preferably about 5 to 7, particularly about 5.5 to 6.5. In the cleaning composition of the present invention, this pH can be maintained for a long time. Specifically, for example, from the pH (25 ° C.) one hour after the sample production and the pH (25 ° C.) of the sample after storage for two months in a 45 ° C. constant temperature bath after the sample production,
When the amount of change in pH is calculated from the equation shown in Equation 2 below,
A cleaning composition whose variation is less than 0.2 is obtained.
【0023】[0023]
【数2】pHの変化量=(製造1時間後のpH)−(45
℃、2ヶ月間保存後のpH)## EQU2 ## pH change = (pH after 1 hour of production)-(45
℃, pH after storage for 2 months)
【0024】本発明の洗浄剤組成物は上記成分に加え
て、目的に応じて本発明の効果を損なわない量的、質的
範囲で、一価アルコール、多価アルコール、多糖類、油
剤、タンパク質誘導体、薬剤、無機酸またはその塩類、
有機酸またはその塩類、酸化防止剤、紫外線吸収剤、色
素、香料など、洗浄剤組成物に一般に配合される成分を
添加してもよい。The detergent composition of the present invention may further comprise, in addition to the above-mentioned components, monohydric alcohols, polyhydric alcohols, polysaccharides, oils, and proteins within a quantitative and qualitative range according to the purpose, without impairing the effects of the present invention. Derivatives, drugs, inorganic acids or their salts,
Components generally blended in the detergent composition, such as organic acids or salts thereof, antioxidants, ultraviolet absorbers, dyes, and fragrances, may be added.
【0025】ここで一価アルコールとしては、エタノー
ル、プロパノール等が挙げられる。Here, examples of the monohydric alcohol include ethanol, propanol and the like.
【0026】多価アルコールとしては、1,2−プロパ
ンジオール、1,3−プロパンジオール、1,2−ブタ
ンジオール、1,3−ブタンジオール、1,4−ブタン
ジオール、ジプロピレングリコール、グリセリン、ジグ
リセリン、ソルビタン、ソルビトール、マルチトール、
グルコース、スクロース等が挙げられる。Examples of the polyhydric alcohol include 1,2-propanediol, 1,3-propanediol, 1,2-butanediol, 1,3-butanediol, 1,4-butanediol, dipropylene glycol, glycerin, Diglycerin, sorbitan, sorbitol, maltitol,
Glucose, sucrose and the like can be mentioned.
【0027】多糖類としては、ヒアルロン酸、コンドロ
イチン硫酸、デルマタン硫酸、ケラタン硫酸、ヘパラン
硫酸およびこれらの塩類が挙げられる。Examples of the polysaccharide include hyaluronic acid, chondroitin sulfate, dermatan sulfate, keratan sulfate, heparan sulfate and salts thereof.
【0028】油剤としては、シリコーン油、炭化水素油
の他、オレンジ油、オリーブオイル、各種ハーブオイル
等の化粧品に汎用される油剤を配合することができる。As oils, oils commonly used in cosmetics such as orange oil, olive oil, and various herb oils can be added in addition to silicone oil and hydrocarbon oil.
【0029】薬剤としては、ビタミンC類、ビタミンE
類、アミノ酸類、生薬、抗炎症剤、殺菌剤等の化粧品に
汎用される薬剤を配合することができる。Drugs include vitamin C, vitamin E
, Amino acids, crude drugs, anti-inflammatory agents, bactericides, and other commonly used cosmetic agents.
【0030】無機酸またはその塩類としては、塩酸、硫
酸、塩化ナトリウム、塩化カリウム等が挙げられる。Examples of the inorganic acids or salts thereof include hydrochloric acid, sulfuric acid, sodium chloride, potassium chloride and the like.
【0031】有機酸またはその塩類としては、クエン
酸、乳酸、酒石酸、フタル酸、クエン酸三ナトリウム、
乳酸ナトリウム等が挙げられる。The organic acids or salts thereof include citric acid, lactic acid, tartaric acid, phthalic acid, trisodium citrate,
Sodium lactate and the like.
【0032】[0032]
【実施例】次に、本発明を実施例によりさらに詳細に説
明するが、本発明はこれによってなんら限定されるもの
ではない。なお、配合量はすべて重量%である。EXAMPLES Next, the present invention will be described in more detail with reference to examples, but the present invention is not limited thereto. In addition, all compounding amounts are weight%.
【0033】実施例に先立ち、各実施例で採用した試験
法、評価法を説明する。Prior to the examples, test methods and evaluation methods employed in each example will be described.
【0034】[安全性(低刺激性):タンパク質変性
率]ドレイズ法の眼刺激強度と良好な相関関係を示す、
ヘモグロビン(Hb)タンパク質を用いたタンパク質変
性(HDR)(%)の測定を行うことにより評価した。
すなわち、マルチプレートリーダーを用いて、ヘモグロ
ビン(Hb)pH6.86緩衝溶液に、試料濃度1%に
なるように試料を加えた場合の混合前後のHbの415
nmの吸光度の変化からタンパク質変性率(HDR)
(%)の測定を行い、以下の通り評価した。[Safety (low irritation): protein denaturation rate] Shows a good correlation with the eye irritation intensity of the Draize method.
Evaluation was performed by measuring protein denaturation (HDR) (%) using hemoglobin (Hb) protein.
That is, when a sample was added to a hemoglobin (Hb) pH 6.86 buffer solution using a multi-plate reader so that the sample concentration became 1%, Hb 415 before and after mixing was measured.
change in protein absorbance (HDR)
(%) Was measured and evaluated as follows.
【0035】[0035]
【数3】HDR(%)={[Ac]−[As]/[A
c]−[Ab]}×100HDR (%) = {[Ac] − [As] / [A
c] − [Ab]} × 100
【0036】ただし、 [Ac]: Hb緩衝溶液の415nm吸光度(コント
ロール) [As]: 被検物質水溶液によるHb変性後の415
nm吸光度 [Ab]: 被検物質水溶液の415nm吸光度[Ac]: Absorbance at 415 nm of Hb buffer solution (control) [As]: 415 after Hb denaturation with aqueous solution of test substance
nm Absorbance [Ab]: 415 nm absorbance of aqueous solution of test substance
【0037】(評価) ◎: HDR 5%未満 ○: HDR 5%以上15%未満 △: HDR 15%以上50%未満 ×: HDR 50%以上(Evaluation) :: HDR less than 5% ○: HDR 5% or more and less than 15% Δ: HDR 15% or more and less than 50% ×: HDR 50% or more
【0038】[粘性・長期粘度安定性]試料製造1時間
後の粘度(25℃)をB型粘度計(12rpm/1mi
n)により測定した。[Viscosity / Long-term Viscosity Stability] The viscosity (25 ° C.) one hour after the sample production was measured using a B-type viscometer (12 rpm / 1 mi).
n).
【0039】また、これとは別に、試料製造後、45℃
恒温槽にて28日間保存した後の試料を25℃恒温槽に
1日保存した後、25℃にてB型粘度計(12rpm/
1min)により測定した。Separately, after the sample is manufactured, the temperature is adjusted to 45 ° C.
After storing the sample in a thermostat for 28 days, the sample was stored in a thermostat at 25 ° C. for 1 day, and then a B-type viscometer (12 rpm /
1 min).
【0040】(粘性の評価) ○: 45℃保存品の粘度(25℃測定)が2000mPa・s以上 △: 45℃保存品の粘度(25℃測定)が500mPa・s以上20
00mPa・s未満 ×: 45℃保存品の粘度(25℃測定)が500mPa・s未満(Evaluation of viscosity) ○: Viscosity of the product stored at 45 ° C. (measured at 25 ° C.) is 2000 mPa · s or more Δ: Viscosity of the product stored at 45 ° C. (measured at 25 ° C.) is 500 mPa · s or more and 20
Less than 00mPa · s ×: Viscosity of the product stored at 45 ° C (measured at 25 ° C) is less than 500mPa · s
【0041】(長期粘度安定性の評価)次式により粘度
の変化率を算出し以下のとおり評価した。(Evaluation of Long-Term Viscosity Stability) The rate of change in viscosity was calculated by the following equation and evaluated as follows.
【0042】[0042]
【数4】粘度の変化率=(45℃、28日間保存後の粘度)
/(製造1時間後の粘度)## EQU4 ## Rate of change in viscosity = (viscosity after storage at 45 ° C. for 28 days)
/ (Viscosity 1 hour after production)
【0043】 ○: 粘度の変化率 0.8以上1.0以下 △: 粘度の変化率 0.6以上0.8未満 ×: 粘度の変化率 0.6未満:: Change rate of viscosity 0.8 or more and 1.0 or less Δ: Change rate of viscosity 0.6 or more and less than 0.8 ×: Change rate of viscosity less than 0.6
【0044】[長期pH安定性]試料製造1時間後のp
H(25℃)をpH測定器により測定した。また、それ
とは別に、試料製造後、45℃恒温槽にて2ヶ月間保存
した後の試料を、25℃にてpH測定器により測定し
た。次式によりpHの変化量を算出し以下のとおり評価
した。[Long-term pH stability] p after 1 hour of sample production
H (25 ° C.) was measured with a pH meter. Separately, the sample was stored at 45 ° C. constant temperature bath for 2 months after the sample was manufactured, and the sample was measured at 25 ° C. using a pH meter. The amount of change in pH was calculated by the following formula and evaluated as follows.
【0045】[0045]
【数5】pHの変化量=(製造1時間後のpH)−(45
℃、2ヶ月間保存後のpH)## EQU5 ## Change in pH = (pH after 1 hour of production)-(45
℃, pH after storage for 2 months)
【0046】(評価) ○: pHの変化量の絶対値 0.2未満 △: pHの変化量の絶対値 0.2以上0.5未満 ×: pHの変化量の絶対値 0.5以上(Evaluation) ○: Absolute value of pH change less than 0.2 △: Absolute value of pH change 0.2 to less than 0.5 ×: Absolute value of pH change 0.5 or more
【0047】(実施例1〜4、比較例1〜4) ヘアシ
ャンプー 下記の表1に記載の配合組成(重量%)からなるヘアシ
ャンプーを常法により調製し、その安全性(Hbタンパ
ク質変性率)、粘性、粘度長期安定性、pH長期安定性
を調べた。結果を表1に示す。(Examples 1 to 4, Comparative Examples 1 to 4) Hair Shampoo A hair shampoo having the composition (% by weight) shown in Table 1 below was prepared by a conventional method, and its safety (Hb protein denaturation rate) ), Viscosity, viscosity long-term stability and pH long-term stability. Table 1 shows the results.
【0048】[0048]
【表1】 表1の結果から明らかなように、本発明のヘアシャンプ
ーは皮膚への安全性に優れ、粘性、粘度長期安定性、p
H長期安定性のいずれにおいても良好な結果を示した。[Table 1] As is evident from the results in Table 1, the hair shampoo of the present invention has excellent skin safety, viscosity, long-term viscosity stability, p
Good results were shown in any of the H long-term stability.
【0049】(実施例5〜6、比較例5〜9) ヘアシ
ャンプー 下記の表2に記載の配合組成(重量%)からなるヘアシ
ャンプーを常法により調製し、その安全性(Hbタンパ
ク質変性率)、粘性、粘度長期安定性、pH長期安定性
を調べた。結果を表2に示す。(Examples 5 to 6, Comparative Examples 5 to 9) Hair shampoo A hair shampoo having the composition (% by weight) shown in Table 2 below was prepared by a conventional method and its safety (Hb protein denaturation rate) ), Viscosity, viscosity long-term stability and pH long-term stability. Table 2 shows the results.
【0050】[0050]
【表2】 表2の結果から明らかなように、本発明のヘアシャンプ
ーは皮膚への安全性に優れ、粘性、粘度長期安定性、p
H長期安定性のいずれにおいても良好な結果を示した。[Table 2] As is evident from the results in Table 2, the hair shampoo of the present invention has excellent skin safety, viscosity, long-term viscosity stability, p
Good results were shown in any of the H long-term stability.
【0051】(実施例7) ヘアシャンプー 常法により実施例7のヘアシャンプーを調製した。(Example 7) Hair shampoo The hair shampoo of Example 7 was prepared by a conventional method.
【0052】 (配 合 成 分) (重量%) N−ヤシ油脂肪酸−N−メチルタウリン トリエタノールアミン 20 N−ドデシルピロリドン 5 「ポリマーJR−400」 0.3 クエン酸 1 グリチルリチン酸ジカリウム 0.1 安息香酸ナトリウム 適 量 香料 適 量 精製水 残 部 (評価)実施例7のヘアシャンプーは、皮膚への安全性
に優れ、粘性、粘度長期安定性、pH長期安定性のいず
れにおいても良好な結果を示した。(Combination component) (% by weight) N-coconut oil fatty acid-N-methyltaurine triethanolamine 20 N-dodecylpyrrolidone 5 “Polymer JR-400” 0.3 citric acid 1 dipotassium glycyrrhizinate 0.1 Sodium benzoate qs perfume qs Purified water balance (Evaluation) The hair shampoo of Example 7 has excellent skin safety and good results in viscosity, viscosity long-term stability and pH long-term stability. Indicated.
【0053】(実施例8) ヘアリンスインシャンプー 常法により実施例8のヘアリンスインシャンプーを調製
した。(Example 8) Hair rinse in shampoo The hair rinse in shampoo of Example 8 was prepared by a conventional method.
【0054】 (配 合 成 分) (重量%) N−ヤシ油脂肪酸−N−メチルタウリンナトリウム 10 N−オクチルピロリドン 4 ポリオキシエチレン(4)ステアリルエーテル 0.1 「ポリマーJR−400」 0.3 ステアリン酸ジメチルアミノプロピルアミド 0.1 クエン酸 0.5 ステアリン酸 0.2 安息香酸ナトリウム 適 量 香料 適 量 精製水 残 部 (評価)実施例8のヘアリンスインシャンプーは、皮膚
への安全性に優れ、粘性、粘度長期安定性、pH長期安
定性のいずれにおいても良好な結果を示した。(Combination component) (% by weight) N-coconut oil fatty acid-N-methyltaurine sodium 10 N-octylpyrrolidone 4 polyoxyethylene (4) stearyl ether 0.1 “Polymer JR-400” 0.3 Dimethylaminopropylamide stearate 0.1 Citric acid 0.5 Stearic acid 0.2 Sodium benzoate qs Perfume qs Purified water balance (Evaluation) The hair rinse in shampoo of Example 8 has excellent skin safety. Good results were shown in all of the viscosity, viscosity long-term stability and pH long-term stability.
【0055】(実施例9) ボディークレンジング 常法により実施例9のボディークレンジングを調製し
た。Example 9 Body Cleansing The body cleansing of Example 9 was prepared by a conventional method.
【0056】 (配 合 成 分) (重量%) N−ヤシ油脂肪酸−N−メチルタウリンナトリウム 6 N−オクチルピロリドン 5 ポリオキシエチレン(8)ベヘニルエーテル 0.1 キサンタンガム 0.8 ヨモギ抽出液 0.1 酢酸トコフェロール 0.1 香料 適 量 精製水 残 部 (評価)実施例9のボディークレンジングは、皮膚への
安全性に優れ、粘性、粘度長期安定性、pH長期安定性
のいずれにおいても良好な結果を示した。(Combined component) (% by weight) N-coconut fatty acid-sodium N-methyltaurine 6 N-octylpyrrolidone 5 polyoxyethylene (8) behenyl ether 0.1 Xanthan gum 0.8 Artemisia extract 0. 1 Tocopherol acetate 0.1 Perfume Appropriate amount Purified water balance (Evaluation) The body cleansing of Example 9 is excellent in safety to skin, and has good results in viscosity, viscosity long-term stability and pH long-term stability. showed that.
【0057】(実施例10) 洗顔液 常法により実施例10の洗顔液を調製した。(Example 10) Face wash The face wash of Example 10 was prepared by a conventional method.
【0058】 (配 合 成 分) (重量%) N−ヤシ油脂肪酸−N−メチルタウリンナトリウム 3 N−ドデシルピロリドン 5 N−ヤシ脂肪酸−N−アミドプロピルベタイン 3 ポリオキシエチレン(3)セチルエーテル 0.1 キサンタンガム 0.3 メントール 0.1 香料 適 量 精製水 残 部 (評価)実施例10の洗顔液は、皮膚への安全性に優
れ、粘性、粘度長期安定性、pH長期安定性のいずれに
おいても良好な結果を示した。(Combination component) (% by weight) N-coconut fatty acid-sodium N-methyltaurine 3 N-dodecylpyrrolidone 5 N-cocofatty acid-N-amidopropylbetaine 3 polyoxyethylene (3) cetyl ether 0 1.1 Xanthan gum 0.3 Menthol 0.1 Perfume Appropriate amount Purified water balance (Evaluation) The face wash of Example 10 has excellent skin safety, and has excellent viscosity, long-term viscosity stability, and long-term pH stability. Also showed good results.
【0059】(実施例11) ボディークレンジング 常法により実施例11のボディークレンジングを調製し
た。Example 11 Body Cleansing The body cleansing of Example 11 was prepared by a conventional method.
【0060】 (配 合 成 分) (重量%) ヤシ油脂肪酸アルギニン 10 N−ヤシ油脂肪酸−N−メチルタウリンナトリウム 6 ポリオキシエチレン(8)ベヘニルエーテル 0.1 N−ドデシルピロリドン 3 香料 適 量 メチルパラベン 適 量 精製水 残 部 (評価)実施例11のボディークレンジングは、皮膚へ
の安全性に優れ、粘性、粘度長期安定性、pH長期安定
性のいずれにおいても良好な結果を示した。(Combination component) (wt%) coconut oil fatty acid arginine 10 N-coconut oil fatty acid-sodium N-methyltaurine 6 polyoxyethylene (8) behenyl ether 0.1 N-dodecylpyrrolidone 3 flavor appropriate amount methylparaben Appropriate amount Purified water Residue (Evaluation) The body cleansing of Example 11 was excellent in skin safety, and showed good results in all of viscosity, long-term viscosity stability and long-term pH stability.
【0061】(実施例12) ボディークレンジング 常法により実施例12のボディークレンジングを調製し
た。Example 12 Body Cleansing The body cleansing of Example 12 was prepared by a conventional method.
【0062】 (配 合 成 分) (重量%) N−ヤシ油脂肪酸−N−メチルタウリンナトリウム 8 N−ヤシ油脂肪酸−N−サルコシントリエタノールアミン 8 アルキルグルコシド 5 1,3−ブチレングリコール 5 N−ドデシルピロリドン 6 エチレングリコールジステアレート 2 安息香酸ナトリウム 適 量 香料 適 量 精製水 残 部 (評価)実施例12のボディークレンジングは、皮膚へ
の安全性に優れ、粘性、粘度長期安定性、pH長期安定
性のいずれにおいても良好な結果を示した。(Combination component) (% by weight) N-coconut fatty acid-sodium N-methyltaurine 8 N-coconut fatty acid-N-sarcosine triethanolamine 8 alkyl glucoside 5 1,3-butylene glycol 5 N- Dodecylpyrrolidone 6 Ethylene glycol distearate 2 Sodium benzoate Appropriate amount Perfume Appropriate amount Purified water balance (Evaluation) Body cleansing of Example 12 is excellent in skin safety, viscosity, viscosity long-term stability, pH long-term stability Good results were obtained in all the properties.
【0063】(実施例13) ボディークレンジング 常法により実施例13のボディークレンジングを調製し
た。Example 13 Body Cleansing The body cleansing of Example 13 was prepared by a conventional method.
【0064】 (配 合 成 分) (重量%) プロピレングリコール 10 ヒドロキシラウリルエーテルカルボン酸 10 N−ヤシ油脂肪酸−N−メチルタウリンマグネシウム 5 ラウリン酸カリウム 5 ミリスチン酸カリウム 5 メチルヒドロキシプロピルセルロース 0.3 エチレングリコールジステアレート 2 N−オクチルピロリドン 3 エチレングリコールジステアレート 2 香料 適 量 エデト酸三ナトリウム 適 量 精製水 残 部 (評価)実施例13のボディークレンジングは、皮膚へ
の安全性に優れ、粘性、粘度長期安定性、pH長期安定
性のいずれにおいても良好な結果を示した。(Combination component) (% by weight) Propylene glycol 10 Hydroxylauryl ether carboxylic acid 10 N-coconut oil fatty acid-N-methyltaurine magnesium 5 Potassium laurate 5 Potassium myristate 5 Methylhydroxypropylcellulose 0.3 Ethylene Glycol distearate 2 N-octylpyrrolidone 3 Ethylene glycol distearate 2 Perfume Appropriate amount Trisodium edetate Appropriate amount Purified water balance (Evaluation) Body cleansing of Example 13 is excellent in safety to skin, Good results were shown in both long-term viscosity stability and long-term pH stability.
【0065】[0065]
【発明の効果】以上詳述したように本発明によれば、ヒ
トの皮膚、毛髪に対して極めて低刺激性であり、商品と
しての価値を満足できる粘性を有し、しかも長い期間が
経過しても粘性が良好に維持され、かつpHの長期安定
性にも優れた洗浄剤組成物が提供される。As described in detail above, according to the present invention, it has extremely low irritation to human skin and hair, has a viscosity that can satisfy the value as a product, and has a long period of time. However, the present invention provides a detergent composition that maintains good viscosity even when the composition is used and has excellent long-term pH stability.
───────────────────────────────────────────────────── フロントページの続き Fターム(参考) 4C083 AA112 AC122 AC172 AC182 AC242 AC302 AC312 AC392 AC482 AC542 AC642 AC662 AC712 AC782 AC791 AC792 AC851 AC852 AD132 AD192 AD282 AD352 AD532 AD662 CC23 CC38 CC39 DD23 EE01 EE06 EE10 4H003 AB23 AD04 AE03 BA12 DA02 EB07 EB08 ED02 FA01 FA02 FA16 FA28 FA30 ──────────────────────────────────────────────────続 き Continued on the front page F term (reference) 4C083 AA112 AC122 AC172 AC182 AC242 AC302 AC312 AC392 AC482 AC542 AC642 AC662 AC712 AC782 AC791 AC792 AC851 AC852 AD132 AD192 AD282 AD352 AD532 AD662 CC23 CC38 CC39 DD23 EE01 EE06 EE10 4H003 AB12 DA03 AE03 EB07 EB08 ED02 FA01 FA02 FA16 FA28 FA30
Claims (2)
は不飽和の脂肪酸残基(アシル基)を表し;R2は水素
原子または平均炭素原子数1〜3のアルキル基を表し;
M1はアルカリ金属類、アルカリ土類金属類、アンモニ
ウムまたは有機アミン類を表す)で表される長鎖アシル
低級アルキルタウリン塩型陰イオン性界面活性剤の1種
または2種以上と、(B)N−アルキルピロリドンの1
種または2種以上とを含有してなる、洗浄剤組成物。(A) The following general formula (I): (Wherein R 1 CO represents a saturated or unsaturated fatty acid residue (acyl group) having an average of 8 to 20 carbon atoms; R 2 represents a hydrogen atom or an alkyl group having an average of 1 to 3 carbon atoms;
M 1 represents an alkali metal, an alkaline earth metal, ammonium or an organic amine) and one or more of long-chain acyl-lower-alkyl-taurine-type anionic surfactants represented by (B) 1) N-alkylpyrrolidone
A cleaning composition comprising a seed or two or more kinds.
ルキル基を表す)で表される化合物である、請求項1記
載の洗浄剤組成物。2. The component (B) has the following general formula (II): (Wherein, R 3 is the average number of carbon atoms represents a linear alkyl group having 8 to 16) is a compound represented by Claim 1 detergent composition.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10254739A JP2000087093A (en) | 1998-09-09 | 1998-09-09 | Detergent composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10254739A JP2000087093A (en) | 1998-09-09 | 1998-09-09 | Detergent composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2000087093A true JP2000087093A (en) | 2000-03-28 |
Family
ID=17269200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10254739A Withdrawn JP2000087093A (en) | 1998-09-09 | 1998-09-09 | Detergent composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2000087093A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003095885A (en) * | 2001-09-21 | 2003-04-03 | Nonogawa Shoji Kk | Hair-rinsing cosmetic |
| JP2004506812A (en) * | 2000-09-01 | 2004-03-04 | ノバファーム リサーチ (オーストラリア) プロプライアタリー リミティッド | Surfactant system |
| JP2007538140A (en) * | 2004-05-20 | 2007-12-27 | アイエスピー インヴェストメンツ インコーポレイテッド | Stable wetting agent concentrate |
| KR100839703B1 (en) | 2006-12-15 | 2008-06-19 | 애경산업(주) | Transparent Fabric Softener Composition |
| JP2019048789A (en) * | 2017-09-12 | 2019-03-28 | 玉理化学株式会社 | Shampoo agent |
-
1998
- 1998-09-09 JP JP10254739A patent/JP2000087093A/en not_active Withdrawn
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004506812A (en) * | 2000-09-01 | 2004-03-04 | ノバファーム リサーチ (オーストラリア) プロプライアタリー リミティッド | Surfactant system |
| JP4896355B2 (en) * | 2000-09-01 | 2012-03-14 | ノバファーム リサーチ (オーストラリア) プロプライアタリー リミティッド | Surfactant system |
| JP2012072409A (en) * | 2000-09-01 | 2012-04-12 | Novapharm Research (Australia) Pty Ltd | Surfactant system |
| JP2003095885A (en) * | 2001-09-21 | 2003-04-03 | Nonogawa Shoji Kk | Hair-rinsing cosmetic |
| JP2007538140A (en) * | 2004-05-20 | 2007-12-27 | アイエスピー インヴェストメンツ インコーポレイテッド | Stable wetting agent concentrate |
| KR100839703B1 (en) | 2006-12-15 | 2008-06-19 | 애경산업(주) | Transparent Fabric Softener Composition |
| JP2019048789A (en) * | 2017-09-12 | 2019-03-28 | 玉理化学株式会社 | Shampoo agent |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5561264B2 (en) | Hair growth composition | |
| JP2964226B2 (en) | Detergent composition | |
| KR101045901B1 (en) | Thickening composition | |
| JP6910867B2 (en) | Oral composition | |
| BRPI1013598B1 (en) | formulations for cleaning and caring for human or animal body parts, which contain esters of sorbitancarboxylic acids and use of esters of sorbitancarboxylic acid in cleaning or care formulations | |
| US5100656A (en) | Preserved hair and body treatment compositions and use of a preservative combination | |
| JPH1067639A (en) | Vitamin E-Vitamin C phosphoric acid diester / cyclodextrin clathrate and external skin preparation containing the clathrate | |
| JP6474963B2 (en) | Cleaning composition | |
| JP3304646B2 (en) | Detergent composition | |
| BR112019001841B1 (en) | FORMULATION FOR BODY WASHING | |
| JP4442912B2 (en) | Composition for external use | |
| JPH11269488A (en) | Detergent composition | |
| JP2000087093A (en) | Detergent composition | |
| JPH09157140A (en) | Shampoo composition | |
| JP2696523B2 (en) | Anti-dandruff agent and hair cosmetic | |
| JP2000129298A (en) | Detergent composition | |
| JP2001064678A (en) | Detergent composition | |
| JP2001226697A (en) | Solid soap | |
| JP3271814B2 (en) | Scalp and hair cosmetics | |
| JP2001288045A (en) | Composition for scalp and hair | |
| JPH0529002B2 (en) | ||
| JP2929305B2 (en) | Skin whitening preparation for external use | |
| KR20240025496A (en) | Skin Cleanser Composition | |
| JP3589568B2 (en) | Detergent composition | |
| JP3263984B2 (en) | Liquid detergent composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A300 | Withdrawal of application because of no request for examination |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20060110 |